PD-L1 over-expression in basal breast tumors has also been associated with increased expression of immune response related genes, with pathways that are involved in T cells activation, differentiation and expression of anti-tumor cytokines and with better response to anthracycline-based neoadjuvant chemotherapy [18, 19]. The gene discussed is CD274; the disease is neoplasm.